Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$3.09M Sell
19,112
-46
-0.2% -$7.54K 0.3% 56
2022
Q4
$2.76M Sell
19,158
-32
-0.2% -$4.74K 0.27% 61
2022
Q3
$2.85M Buy
+19,190
New +$3.21M 0.31% 56
2022
Q2
Sell
-19,101
Closed -$3.6M 330
2022
Q1
$3.6M Sell
19,101
-253
-1% -$50K 0.34% 54
2021
Q4
$4.72M Buy
19,354
+39
+0.2% +$8.54K 0.46% 45
2021
Q3
$3.75M Sell
19,315
-140
-0.7% -$28.3K 0.46% 46
2021
Q2
$3.63M Buy
19,455
+80
+0.4% +$13.9K 0.44% 47
2021
Q1
$3.05M Buy
+19,375
New +$3.07M 0.41% 50

Other funds holding ZTS

HighTower Trust's ZTS Position: Q1 2023 in Review

HighTower Trust reduced its Zoetis (ZTS) stake by 0.24% in Q1 2023, selling an estimated $7.54K and leaving 19,112 shares worth $3.09M. The position accounts for 0.3% of the portfolio, ranked #56.

HighTower Trust first reported a position in ZTS in Q1 2021 and has held it in 8 quarters since. The position peaked at $4.72M in Q4 2021. 1,557 funds tracked by Wall St. Rank hold ZTS as of Q1 2023.

  • HighTower Trust held 19,112 shares of Zoetis worth $3.09M as of Q1 2023.
  • HighTower Trust sold 46 Zoetis shares in Q1 2023, an estimated $7.54K.
  • Zoetis made up 0.3% of HighTower Trust's portfolio in Q1 2023, its #56 holding.
  • HighTower Trust first reported a position in Zoetis in Q1 2021 and has held it in 8 quarters since.
  • HighTower Trust's Zoetis position peaked at $4.72M in Q4 2021.
  • 1,557 funds tracked by Wall St. Rank held Zoetis as of Q1 2023.

Based on HighTower Trust's 13F filing for Q1 2023, filed 21 Apr 2023.